Celldex Therapeutics Current Ratio 2006-2018 | CLDX

Current and historical current ratio for Celldex Therapeutics (CLDX) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Celldex Therapeutics current ratio for the three months ending September 30, 2018 was 6.59.
Celldex Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.11B $0.02B 6.59
2018-06-30 $0.12B $0.02B 6.02
2018-03-31 $0.13B $0.02B 5.45
2017-12-31 $0.15B $0.03B 5.22
2017-09-30 $0.15B $0.03B 5.91
2017-06-30 $0.16B $0.03B 5.56
2017-03-31 $0.17B $0.03B 6.42
2016-12-31 $0.20B $0.04B 5.55
2016-09-30 $0.21B $0.02B 11.26
2016-06-30 $0.23B $0.02B 11.44
2016-03-31 $0.26B $0.03B 10.31
2015-12-31 $0.30B $0.03B 9.75
2015-09-30 $0.31B $0.02B 13.09
2015-06-30 $0.34B $0.03B 12.72
2015-03-31 $0.36B $0.02B 17.22
2014-12-31 $0.21B $0.02B 8.37
2014-09-30 $0.23B $0.02B 10.63
2014-06-30 $0.26B $0.02B 12.06
2014-03-31 $0.28B $0.02B 14.19
2013-12-31 $0.31B $0.02B 15.00
2013-09-30 $0.14B $0.02B 8.33
2013-06-30 $0.16B $0.01B 12.51
2013-03-31 $0.18B $0.02B 10.06
2012-12-31 $0.09B $0.02B 4.81
2012-09-30 $0.08B $0.02B 5.21
2012-06-30 $0.08B $0.01B 6.39
2012-03-31 $0.09B $0.01B 7.51
2011-12-31 $0.06B $0.01B 3.83
2011-09-30 $0.06B $0.01B 5.97
2011-06-30 $0.07B $0.01B 7.04
2011-03-31 $0.05B $0.01B 5.18
2010-12-31 $0.06B $0.02B 3.12
2010-09-30 $0.06B $0.02B 2.54
2010-06-30 $0.07B $0.02B 2.88
2010-03-31 $0.08B $0.03B 3.15
2009-12-31 $0.08B $0.01B 5.83
2009-09-30 $0.03B $0.01B 1.99
2009-06-30 $0.03B $0.01B 2.61
2009-03-31 $0.04B $0.01B 2.98
2008-12-31 $0.05B $0.01B 3.34
2008-09-30 $0.06B $0.02B 3.02
2008-06-30 $0.07B $0.02B 3.43
2008-03-31 $0.02B $0.01B 1.98
2007-12-31 $0.01B $0.01B 0.56
2007-09-30 $0.02B $0.01B 2.44
2007-06-30 $0.03B $0.01B 3.23
2007-03-31 $0.03B $0.01B 3.32
2006-12-31 $0.04B $0.01B 4.21
2006-09-30 $0.05B $0.01B 5.85
2006-06-30 $0.06B $0.01B 8.34
2006-03-31 $0.06B $0.01B 9.40
2005-12-31 $0.03B $0.00B 6.66
2005-09-30 $0.03B $0.00B 7.97
2005-06-30 $0.03B $0.00B 9.25
2005-03-31 $0.03B $0.01B 6.28
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.063B $0.013B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.085B 13.92
Gilead Sciences (GILD) United States $92.080B 11.09
Biogen (BIIB) United States $65.522B 13.27
Celgene (CELG) United States $51.759B 10.04
Illumina (ILMN) United States $48.400B 56.38
Vertex Pharmaceuticals (VRTX) United States $46.141B 80.60
Regeneron Pharmaceuticals (REGN) United States $38.539B 19.55
Alexion Pharmaceuticals (ALXN) United States $27.539B 18.85
BioMarin Pharmaceutical (BMRN) United States $17.035B 0.00
Incyte (INCY) United States $14.052B 388.41
Seattle Genetics (SGEN) United States $9.298B 0.00
Exact Sciences (EXAS) United States $9.171B 0.00
Sarepta Therapeutics (SRPT) United States $8.384B 0.00
QIAGEN (QGEN) Netherlands $8.210B 26.25
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
Alnylam Pharmaceuticals (ALNY) United States $7.316B 0.00
Bluebird Bio (BLUE) United States $6.910B 0.00
BeiGene (BGNE) Cayman Islands $6.519B 0.00
Bio-Techne Corp (TECH) United States $6.450B 43.57
Amarin (AMRN) Ireland $6.153B 0.00
Alkermes (ALKS) Ireland $5.853B 3767.00
Galapagos (GLPG) Belgium $5.430B 0.00
Exelixis (EXEL) United States $4.984B 14.13
Immunomedics (IMMU) United States $4.079B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.787B 0.00
Horizon Pharma Public (HZNP) Ireland $3.736B 15.37
Array BioPharma (ARRY) United States $3.565B 0.00
Allogene Therapeutics (ALLO) United States $3.528B 0.00
Emergent Biosolutions (EBS) United States $3.441B 28.99
Ligand Pharmaceuticals (LGND) United States $3.347B 25.79
Intercept Pharmaceuticals (ICPT) United States $3.227B 0.00
Guardant Health (GH) United States $3.184B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.131B 0.00
Repligen (RGEN) United States $2.971B 92.79
Genomic Health (GHDX) United States $2.928B 99.60
Ascendis Pharma (ASND) Denmark $2.664B 0.00
Blueprint Medicines (BPMC) United States $2.643B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.642B 0.00
Acceleron Pharma (XLRN) United States $2.535B 0.00
REGENXBIO (RGNX) United States $2.379B 31.91
ACADIA Pharmaceuticals (ACAD) United States $2.359B 0.00
MyoKardia (MYOK) United States $2.333B 0.00
Myriad Genetics (MYGN) United States $2.306B 22.85
Halozyme Therapeutics (HALO) United States $2.297B 51.26
China Biologic Products (CBPO) China $2.294B 16.33
Akcea Therapeutics (AKCA) United States $2.274B 0.00
Allakos (ALLK) United States $2.239B 0.00
Global Blood Therapeutics (GBT) United States $2.084B 0.00
Amicus Therapeutics (FOLD) United States $2.005B 0.00
Reata Pharmaceuticals (RETA) United States $1.952B 0.00
AnaptysBio (ANAB) United States $1.935B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.887B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.862B 0.00
Arena Pharmaceuticals (ARNA) United States $1.792B 0.00
Aimmune Therapeutics (AIMT) United States $1.779B 0.00
Medicines (MDCO) United States $1.757B 0.00
Cambrex (CBM) United States $1.719B 12.84
G1 THERAPEUTICS (GTHX) United States $1.698B 0.00
Innoviva (INVA) United States $1.656B 9.37
Atara Biotherapeutics (ATRA) United States $1.654B 0.00
Spark Therapeutics (ONCE) United States $1.614B 0.00
Denali Therapeutics (DNLI) United States $1.584B 0.00
NeoGenomics (NEO) United States $1.578B 130.54
Biohaven Pharmaceutical Holding (BHVN) United States $1.562B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.436B 0.00
Editas Medicine (EDIT) United States $1.384B 0.00
Myovant Sciences (MYOV) United Kingdom $1.300B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Mirati Therapeutics (MRTX) United States $1.286B 0.00
WAVE Life Sciences (WVE) Singapore $1.266B 0.00
Insmed (INSM) United States $1.261B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.249B 99.21
Rubius Therapeutics (RUBY) United States $1.240B 0.00
Sangamo Therapeutics (SGMO) United States $1.134B 0.00
Cellectis (CLLS) France $1.103B 0.00
DBV Technologies (DBVT) France $1.095B 0.00
Solid Biosciences (SLDB) United States $1.075B 0.00
Retrophin (RTRX) United States $1.063B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.030B 0.00
Audentes Therapeutics (BOLD) United States $1.025B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.003B 0.00
Intra-Cellular Therapies (ITCI) United States $0.990B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.986B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.983B 0.00
UniQure (QURE) Netherlands $0.959B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.950B 0.00
Acorda Therapeutics (ACOR) United States $0.949B 12.02
Alder BioPharmaceuticals (ALDR) United States $0.948B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.923B 0.00
Puma Biotechnology (PBYI) United States $0.891B 0.00
Viking Therapeutics (VKTX) United States $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.868B 0.00
Aptinyx (APTX) United States $0.867B 0.00
Lion Biotechnologies (IOVA) United States $0.857B 0.00
Apellis Pharmaceuticals (APLS) United States $0.834B 0.00
Fate Therapeutics (FATE) United States $0.827B 0.00
Clovis Oncology (CLVS) United States $0.825B 0.00
Intellia Therapeutics (NTLA) United States $0.815B 0.00
Athenex (ATNX) United States $0.808B 0.00
Heska (HSKA) United States $0.782B 63.97
Cara Therapeutics (CARA) United States $0.773B 0.00
InflaRx (IFRX) Germany $0.760B 0.00
Dynavax Technologies (DVAX) United States $0.758B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.753B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.739B 0.00
Mesoblast (MESO) Australia $0.714B 0.00
Vericel (VCEL) United States $0.698B 0.00
Novavax (NVAX) United States $0.685B 0.00
Coherus BioSciences (CHRS) United States $0.684B 0.00
AVROBIO (AVRO) United States $0.684B 0.00
Gritstone Oncology (GRTS) United States $0.680B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.677B 0.00
CytomX Therapeutics (CTMX) United States $0.675B 0.00
UROGEN PHARMA (URGN) Israel $0.642B 0.00
Scholar Rock Holding (SRRK) United States $0.631B 0.00
ANI Pharmaceuticals (ANIP) United States $0.623B 11.94
AMAG Pharmaceuticals (AMAG) United States $0.616B 0.00
Epizyme (EPZM) United States $0.614B 0.00
Senesco Technologies (ELOX) United States $0.599B 0.00
Arvinas (ARVN) United States $0.592B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.583B 0.00
AC Immune SA (ACIU) Switzerland $0.575B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.575B 0.00
Principia Biopharma (PRNB) United States $0.566B 0.00
ObsEva SA (OBSV) Switzerland $0.559B 0.00
Arcus Biosciences (RCUS) United States $0.545B 0.00
Anika Therapeutics (ANIK) United States $0.543B 22.49
UNITY Biotechnology (UBX) $0.504B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
Inovio Pharmaceuticals (INO) United States $0.484B 0.00
Kezar Life Sciences (KZR) United States $0.470B 0.00
Eidos Therapeutics (EIDX) United States $0.467B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.456B 0.00
Kura Oncology (KURA) United States $0.456B 0.00
Replimune (REPL) United States $0.455B 0.00
Kindred Biosciences (KIN) United States $0.454B 0.00
BeyondSpring (BYSI) United States $0.453B 0.00
Abeona Therapeutics (ABEO) United States $0.449B 0.00
Zymeworks (ZYME) Canada $0.441B 0.00
Sinovac Biotech (SVA) China $0.438B 0.00
MediciNova (MNOV) United States $0.434B 0.00
Sorrento Therapeutics (SRNE) United States $0.428B 73.40
Zealand Pharma (ZEAL) Denmark $0.427B 0.00
Stemline Therapeutics (STML) United States $0.420B 0.00
PDL BioPharma (PDLI) United States $0.417B 6.81
Five Prime Therapeutics (FPRX) United States $0.410B 0.00
Verastem (VSTM) United States $0.406B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.396B 0.00
Cytokineticsorporated (CYTK) United States $0.389B 0.00
RA PHARMCTL INC (RARX) United States $0.388B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.357B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.350B 0.00
Seres Therapeutics (MCRB) United States $0.343B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.332B 0.00
LogicBio Therapeutics (LOGC) United States $0.331B 0.00
Krystal Biotech (KRYS) United States $0.322B 0.00
ResTORbio (TORC) United States $0.319B 0.00
Kodiak Sciences (KOD) United States $0.316B 0.00
Merus (MRUS) Netherlands $0.311B 0.00
Albireo Pharma (ALBO) United States $0.309B 0.00
Geron (GERN) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
Sutro Biopharma (STRO) United States $0.306B 0.00
Kadmon Holdings (KDMN) United States $0.299B 0.00
Liquidia Technologies (LQDA) United States $0.295B 0.00
MannKind (MNKD) United States $0.292B 0.00
Aduro Biotech (ADRO) United States $0.288B 0.00
Magenta Therapeutics (MGTA) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.288B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.281B 0.00
Celcuity (CELC) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.276B 0.00
Equillium (EQ) United States $0.276B 0.00
Strongbridge Biopharma (SBBP) United States $0.272B 0.00
BioDelivery Sciences (BDSI) United States $0.267B 0.00
Athersys (ATHX) United States $0.265B 0.00
TOCAGEN INC (TOCA) United States $0.261B 0.00
Arbutus Biopharma (ABUS) Canada $0.258B 0.00
Proteostasis Therapeutics (PTI) United States $0.258B 0.00
Evelo Biosciences (EVLO) United States $0.255B 0.00
Axovant Sciences (AXON) United Kingdom $0.254B 0.00
Syros Pharmaceuticals (SYRS) United States $0.248B 0.00
ADMA Biologics Inc (ADMA) United States $0.244B 0.00
Kala Pharmaceuticals (KALA) United States $0.243B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.239B 0.00
Agenus (AGEN) United States $0.239B 0.00
Adverum Biotechnologies (ADVM) United States $0.236B 0.00
Protagonist Therapeutics (PTGX) United States $0.235B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.232B 0.00
Urovant Sciences (UROV) United States $0.231B 0.00
Idera Pharmaceuticals (IDRA) United States $0.228B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.221B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.218B 0.00
NantKwest (NK) United States $0.218B 0.00
Kamada (KMDA) Israel $0.215B 16.69
Unum Therapeutics (UMRX) United States $0.215B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.212B 0.00
Synlogic (SYBX) United States $0.203B 0.00
ChromaDex (CDXC) United States $0.200B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.199B 0.00
Intec Pharma (NTEC) Israel $0.193B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.193B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.184B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.182B 0.00
Cerecor (CERC) United States $0.177B 18.13
PSivida (EYPT) United States $0.171B 0.00
Compugen (CGEN) Israel $0.171B 0.00
Menlo Therapeutics (MNLO) United States $0.171B 0.00
Allena Pharmaceuticals (ALNA) United States $0.168B 0.00
Cohbar (CWBR) United States $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.156B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.155B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.154B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Constellation Pharmaceuticals (CNST) United States $0.151B 0.00
Cue Biopharma (CUE) United States $0.144B 0.00
Mustang Bio (MBIO) United States $0.143B 0.00
Mersana Therapeutics (MRSN) United States $0.142B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.138B 0.00
XBiotech (XBIT) United States $0.138B 0.00
Eleven Biotherapeutics (SESN) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.138B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.135B 0.00
Organovo Holdings (ONVO) United States $0.132B 0.00
VBI Vaccines (VBIV) United States $0.132B 0.00
OVID THERAPEUTC (OVID) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.124B 0.00
Applied Genetic Technologies (AGTC) United States $0.121B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
XOMA (XOMA) United States $0.121B 0.00
Signal Genetics (MGEN) United States $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.119B 0.00
Anavex Life Sciences (AVXL) United States $0.119B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.117B 0.00
Cidara Therapeutics (CDTX) United States $0.112B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Provention Bio (PRVB) United States $0.107B 0.00
Axsome Therapeutics (AXSM) United States $0.102B 0.00
Chiasma (CHMA) United States $0.100B 0.00
Monster Digital (INNT) United States $0.100B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
BioXcel Therapeutics (BTAI) United States $0.092B 0.00
Ophthotech (OPHT) United States $0.092B 0.00
Orgenesis (ORGS) United States $0.092B 0.00
VTv Therapeutics (VTVT) United States $0.091B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Prima BioMed (IMMP) Australia $0.088B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Checkpoint Therapeutics (CKPT) United States $0.085B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
NewLink Genetics (NLNK) United States $0.077B 0.00
Aptevo Therapeutics (APVO) United States $0.076B 0.00
Evogene (EVGN) Israel $0.076B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Alcobra (ARCT) United States $0.075B 0.00
ITUS (ANIX) United States $0.070B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.069B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Bellerophon Therapeutics (BLPH) United States $0.062B 0.00
VistaGen Therapeutics (VTGN) United States $0.062B 0.00
Sophiris Bio (SPHS) United States $0.062B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.061B 9.94
Leap Therapeutics (LPTX) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Fortress Biotech (FBIO) United States $0.060B 0.00
Clearside Biomedical (CLSD) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.058B 0.00
Cocrystal Pharma (COCP) United States $0.055B 0.00
Trevena (TRVN) United States $0.054B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.052B 0.00
Curis (CRIS) United States $0.052B 0.00
OncoSec Medical (ONCS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Oncolytics Biotech (ONCY) Canada $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.045B 0.00
TRACON Pharmaceuticals (TCON) United States $0.043B 0.00
Versartis (ARAV) United States $0.042B 6.89
AquaBounty Technologies (AQB) United States $0.042B 0.00
AZURRX BIOPHARM (AZRX) United States $0.041B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
Celsion (CLSN) United States $0.039B 0.00
VIVUS (VVUS) United States $0.039B 0.00
GTx (GTXI) United States $0.037B 0.00
AEterna Zentaris (AEZS) United States $0.037B 7.06
Moleculin Biotech (MBRX) United States $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Galena Biopharma (SLS) United States $0.036B 0.00
Proteon Therapeutics (PRTO) United States $0.033B 0.00
Novelion Therapeutics (NVLN) Canada $0.032B 0.00
Aileron Therapeutics (ALRN) United States $0.030B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Vical (VICL) United States $0.029B 0.00
Therapix Biosciences (TRPX) Israel $0.029B 10.62
CytRx (CYTR) United States $0.027B 0.00
OvaScience (OVAS) United States $0.026B 0.00
Cellect Biotechnology (APOP) Israel $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.024B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Arsanis (ASNS) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.015B 0.00
Histogenics (HSGX) United States $0.015B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Adial Pharmaceuticals (ADIL) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00